01 August 2005
Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe pre-eclampsia
Hussein Qublan, Vera Ammarin, Osama Bataineh, Ziad Al-Shraideh, Yosef Tahat, Islam Awamleh, Basel Khreisat, Bassam Nussair, Zouhair AmarinMed Sci Monit 2005; 11(8): CR393-397 :: ID: 201700
Abstract
Background: Pre-eclampsia is a specific disease of pregnancy with multisystemcomplications. We conducted this study to examine the relationship between lactic dehydrogenase concentrationand the severity of the disease and the occurrence of its complications. Material/Methods: One hundredeleven pre-eclamptic women (49 with mild and 62 with severe pre-eclampsia) and 60 healthy normotensivecontrols were studied prospectively at the King Hussein Medical Center between January and December 2002.Demographic, hemodynamic, and laboratory data were compared among the three groups. The symptoms andcomplications of severe pre-eclampsia along with fetal outcome were analyzed according to the levelsof LDH (800 IU/l). One-way analysis of variance (ANOVA) and the chi-square test wereused to compare the results. Differences were considered significant when p800 IU/l compared withthose who had lower levels. Conclusions: Lactic dehydrogenase is a useful biochemical marker that reflectsthe severity of and the occurrence of complications of pre-eclampsia. Identification of high-risk patientswith elevated levels of lactic dehydrogenase, their close monitoring, and prompt, correct managementmay prevent these complications, with a subsequent decrease in maternal and fetal morbidity and mortality.
Keywords: Pre-Eclampsia - diagnosis, Biological Markers - analysis, L-Lactate Dehydrogenase - metabolism, Pre-Eclampsia - pathology, Pregnancy, Pregnancy Outcome, Prospective Studies
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952